Carmen Herrero

Archivel Farma SL provides research and development services to the pharmaceutical sector. It focuses on TB, more specifically, on the treatment of the latent TB infection diseases. The firm is association with the Germans Trias i Pujol Research Institut of Health Sciences and the Germans Trias i Pujol University Hospital has developed RUTI, the first therapeutic vaccine against TB. The company was founded in 2005 by José Martínez, Pere-Joan Cardona i Iglèsias, Jaume Amat i Reira and Isabel Amat i Riera and is headquartered in Badalona, Spain.

Almirall Ltd. is an international pharmaceutical company based on innovation and committed to health, headquartered in Barcelona, Spain. In Almirall they research, develop, produce and market proprietary R&D medicines and those under licence with the aim of improving people's health and wellbeing. They devote big human and economic resources to constant research into new drugs and to obtaining effective and safe products against discomfort and disease.

Asociacion De Empresas Biotecnologicas operates as a Spanish biotechnology company. The private company is based in Madrid, Spain.

Aquilón Cyl SL develops vaccines and probiotics to combat swine diseases. It develops the findings and inventions of Spanish research, basically in the veterinary medicine field. The company was founded by Nistal Pedro Miguel Rubio in March, 2012 and is headquartered in Leon, Spain.

Immuni Therapeutics SL is a Spanish company that develops vaccines against COVID-19 and other viruses. The private company is based in Badalona, Spain. Immuni Therapeutics is promoted by Archivel Farma, the owner of the Ruti vaccine, which has yielded the rights for its development and commercialization to the new company. The Ruti vaccine is unique as it is based on the potentiation of the "trained innate immunity" in the patient, making it compatible with other vaccines and better adapted to the possible mutations of the virus or the arrival of new ones. Luis Antonio Ruiz-Avila has been the CEO of the company since 2020.

Leukos Biotech SL develops of new treatments for acute myeloid leukaemia and other haematological malignancies. The company was founded by Ruth Munoz Risueño in 2015 and is headquartered in Barcelona, Spain.

l'Associació Catalana d'Empreses de Biotecnologia is business association operating company. It is engaged in promoting health and life sciences activities for biotechnology organizations, business leaders, senior executives, entrepreneurs, investors and journalists. The company was founded in 2006 and is headquartered in Barcelona, Spain.

Fastbase Solutions SL operates an online cancer diagnostic software platform. The company is based in Derio, Spain. Fernando Aguirre has been the CEO of the Spanish company since 2018.

Antalgenics SL is a Spanish biotechnological company that specializes in discovering and developing new bioactive molecules for biomedical and dermocosmetic applications. The company is based in Alicante, Spain. The company offers customized R & D services to design and develop projects according to the client's needs. The company's focus is on developing novel therapeutic leads, primarily for the treatment of psoriatic pruritus and psoriatic comorbidities. Antalgenics was founded in 2015, and the CEO is Philipp Tsolakis.

Prospera Biotech SL is a Spanish company that develops innovative solutions for sensitive skin caused by medical treatments and environmental agents. The company is based in Elche, Spain and was founded in 2019. The company's own formulations are free of aggressive agents and suitable for all types of skin. The company specializes in developing cosmetic formulations with innovative neurocosmetics for skin care in sensitive skin with a tendency to atopia, sensitive skins of people who have received chemotherapy and/or radiotherapy, sensitive skins in the intimate parts of the body, and excessive sweating. The CEO is Marta García.